Pediatric Injectable Drugs
The Teddy Bear Book
List Price: $225.00
Member Price: $171.00
Page Count: 1240
Pediatric Injectable Drugs, also known as “The Teddy Bear Book,” is one of ASHP’s most recognized and trusted resources dedicated to providing guidance on the use of injectable medications in children. For more than 25 years, pharmacists, physicians, nurses, and other health professionals have relied on The Teddy Bear Book to provide the most comprehensive research-based information on administering injectable medications to children.
NOTE: The link below allows you to download the ePub file. If you want the PDF files, click on Table of Contents, browse the chapters by clicking on the drop-down symbol ^, select a chapter, and you will see the DOWNLOAD PDF orange button in the upper right. Most ePub files can be opened in eBook readers, like the B&N Nook and Kobo eReader. These files have to be converted to .Mobi format before they are usable on the Amazon Kindle device or app. For your computer, the easiest way to open an ePub file is to double-click on it and let your PC decide which default application should open the file. If no program opens it, then you probably do not have an application installed that can view ePub files. ePub files can also be opened on a computer with various free programs including Adobe Digital Editions. If you have access to this title you can download the ePub here:
- Pediatric Injectable Drugs (EPUB 3.03 MB)
- Pediatric Injectable Drugs (PDF 9.61 MB)
The Teddy Bear Book is the only reference of its kind that focuses on the unique issues that healthcare professionals face when using injectable medications in children, such as limited fluid volumes, maximum concentrations, and rates of administration.
The 12th Edition features more than 270 updated monographs (including over 40 monographs new to this edition) that cover the following areas:
- Safety issues
- Infusion-related cautions
- Dosages and conditions requiring dosage adjustments
- Contraindications and warnings
- Adverse drug effects
- Preparation and compatibility
- Bolus, intermittent, and continuous IV administration
- Monitoring
New monographs include:
- Ansuvumab
- Antihemophilic Factor (Recombinant) Factor VIII pegylated
- Bevacizumab
- Blinatumomab
- Brentuximab
- Brivarcetam
- Calaspargase Pegol
- Ceftazidime Avibactam
- Ceftolozane Tazobactam
- Cetirizine HCl
- Crizanlizumab
- Dalbavancin
- Daunorubicin and Cytarabine, Liposome
- Defibrotide
- Dinutuximab
- Dupilumab
- Eculizumab
- Elapegademase Lvlr
- Emapalumab-lzsg
- Emicizumab
- Factor IX (Recombinant Albumin Fusion Protein)
- Factor IX (Recombinant Fc Fusion Protein)
- Factor IX (Recombinant Glycopegylated)
- Factor IX (Recombinant)
- Factor X concentrate (Human)
- Factor XIII concentrate (Human)
- Factor XIII a-subunit (Recombinant)
- Ferric Carboxymaltose
- Ferric Derisomaltose
- Ferumoxytol
- Gemtuzumab
- Inotuzumab
- Ipilimumab
- Methoxy Polyethylene Glycol-Epoetin Beta
- Nalbuphine HCl
- Nivolumab
- Onasemnogene Abeparvovec
- Pembrolizumab
- Remdesivir
- Tedizolid
- Tocilizumab
New features added to all monographs:
- Expanded monograph layout
- Pronunciations
- Enhanced safety information including ASHP’s Standardize 4 Safety concentration standards, and The KIDs List
- AHFS® Pharmacologic-Therapeutic Classification© specific category identification
Stephanie J. Phelps, PharmD, FAPhA, FCCP, FNAP, FPPA
Stephanie J. Phelps received her baccalaureate pharmacy degree from Samford University and a doctor of pharmacy degree from The University of Tennessee Health Science Center (UTHSC), Memphis, Tennessee. She subsequently completed postdoctoral training in pediatrics at Le Bonheur Children’s Medical Center and UTHSC. Dr. Phelps is currently a Professor Emeritus of Clinical Pharmacy and Translational Science and Pediatrics at UTHSC.
Phelps is an elected Fellow of the American College of Clinical Pharmacy (ACCP), the American Pharmacists Association (APhA), the National Academies of Practice (NAP), and the Pediatric Pharmacy Assocation (PPA). Dr. Phelps has held elected offices in AACP, ASHP, and NAP and has served on the Board of Directors of the American Society of Parenteral and Enteral Nutrition (ASPEN) and the PPA. She is a past chair of the Pharmacy Academy of the National Academies of Practice. She has received several awards including the APhA Academy of Student Pharmacists (ASP) Outstanding Chapter Advisor Award, the 2016 APhA Linwood F. Tice Friend of APhA–ASP Award, the 2009 Tennessee Society of Hospital Pharmacy’s Distinguished Service Award, the 2011 Helms Award for Excellence in Pediatric Pharmacy Practice from PPAG, the 2013 ACCP Education Award, and the 2020 Piocoro Pioneer in Pediatric Pharmacy Award from the University of Kentucky. During her career, Dr. Phelps has participated in the education of five postdoctoral fellows and over 70 pediatric pharmacy residents. She served as editor-in-chief of the Journal of Pediatric Pharmacology and Therapeutics for almost two decades and has published numerous manuscripts, book chapters, and reviews that focus on pediatric pharmacotherapy.
Tracy M. Hagemann, PharmD, MS, FCCP, FPPA
Tracy M. Hagemann received her doctor of pharmacy degree from the University of Missouri–Kansas City School of Pharmacy. She completed a pharmacy practice residency at the Regional Medical Center in Memphis, Tennessee, followed by a pediatric specialty residency at the University of Oklahoma and Children’s Hospital at OU Medical Center in Oklahoma City, Oklahoma. Dr. Hagemann is currently Professor and Associate Dean at The University of Tennessee College of Pharmacy, Nashville Campus. Previously, she was faculty at The University of Oklahoma College of Pharmacy, with an active practice in pediatric hematology and oncology at The Children’s Hospital at OU Medical Center. Her focus of practice and research is in pediatric hematology and oncology.
Hagemann is an elected fellow of both the American College of Clinical Pharmacy (ACCP) and the Pediatric Pharmacy Association (PPA). She is an active member of various national pharmacy organizations and has held elected offices at PPA and ACCP, as well as the Oklahoma Society of Health-System Pharmacists. Dr. Hagemann has published book chapters in pediatric sickle cell disease, and her teaching and research have resulted in the publication of over 70 peer-reviewed journal articles and over 100 scientific abstracts.
Kelley R. Lee, PharmD, BCPS
Kelley R. Lee received her doctor of pharmacy degree from The University of Tennessee Health Science Center (UTHSC). She completed a two-year residency in pediatric pharmacotherapy at Le Bonheur Children’s Hospital and UTHSC. After residency training, Dr. Lee served as a Clinical Pharmacy Specialist and then the Clinical Pharmacy Manager at Le Bonheur Children’s Hospital and part-time Professor of Clinical Pharmacy at UTHSC. She now focuses on infectious diseases and is currently a Clinical Pharmacy Specialist in Antimicrobial Stewardship at Le Bonheur Children’s Hospital.
Lee’s practice and research interests have primarily been the appropriate use of medications in pediatric patients, particularly with the use of antibiotics. Dr. Lee has participated in training pediatric pharmacy residents throughout her career and has recently helped establish a pediatric infectious diseases residency program and helped create an antibiotic stewardship rotation for Pediatric Infectious Diseases Fellows. In addition to serving as both an author and a contributing writer for several editions of this book, she has published numerous manuscripts, abstracts, and letters-to-the-editor on pediatrics.
“This is the gold standard for information on all aspects of intravenous medication administration in neonates, infants, children and adolescents. A copy of this book should be available in every pediatric patient care unit.”
Ina Lee Calligaro, PharmD
© 2024 American Society of Health-System Pharmacists. All Rights Reserved.